Product Technology Sample Clauses

Product Technology. Ownership of all patentable inventions discovered in the course of the Research Collaboration that constitute Product Technology (specifically including, but not limited to composition of matter claims to Alliance Genes) shall be solely determined based on comparative relevance to the Biosource Field and the TDCC Field. The parties shall have an obligation to assign rights to each other as follows: (i) Biosource shall solely own all patentable inventions discovered in the course of the Research Collaboration that constitute Product Technology, where the sole use of the Product Technology is in the Biosource Field; provided, however, that any development of inventions in the Biosource Field shall not be part of Research Services. In the event that one or more employees of TDCC or DAS is an inventor of such an invention, TDCC or DAS, as appropriate, shall cause such employees to assign all of his/her rights in such invention, including all intellectual property rights therein, to Biosource; (ii) TDCC shall solely own all patentable inventions discovered in the course of the Research Collaboration that constitute Product Technology, where the sole use of the Product Technology is in the TDCC Field, or relate to genes, nucleotide sequences or fragments thereof of Photorhabdus, Xenorhabdus, Bacillus thuringiensis, and Saccharopolyspora spinosa or Demeter Genes. In the event that one or more employees of Biosource is an inventor of such an invention, Biosource shall cause such employee(s) to assign all of his/her rights in such invention, including all intellectual property rights therein, to TDCC; (iii) where patentable inventions are discovered in the course of the Research Collaboration that constitute Product Technology that have uses in both the Biosource Field and TDCC Field, the invention shall be Owned solely by TDCC. In the event that one or more employees of a party is an inventor of such a patentable invention Owned by another party under this Section 7.1.1(c), the party shall cause such employee(s) to assign all of his/her rights in such invention, including all intellectual property rights therein, to the party having ownership hereunder .
Product Technology. As between the Parties, Licensee shall own and, subject to the licenses and rights of reference granted in Article 3, retain all right, title and interest in and to any and all Product Technology. MTI will, and does hereby, assign to Licensee and will cause each of its officers, directors, employees, Affiliates, subcontractors and agents to assign to Licensee all such right, title and interest in and to any Product Technology, without additional compensation, as is necessary to fully effect the sole ownership provided for in the first sentence of this Section 10.2.3.
Product Technology. Perrigo shall promptly disclose to Medicis all Product Technology. Medicis shall solely own all right, title and interest in and to the Product Technology and all patent and other intellectual property rights therein. Perrigo hereby assigns to Medicis all of its right, title and interest in and to the Product Technology and all patent and other intellectual property rights therein. Perrigo shall perform, during and after the term of this Agreement, all acts that Medicis reasonably deems necessary or desirable to permit and assist Medicis, at Medicis’ expense, in obtaining, perfecting and enforcing the full benefits, enjoyment, rights and title throughout the world in the Product Technology and all patent and other intellectual property rights therein. If Medicis is unable for any reason to secure Perrigo’s signature to any document required to file, prosecute, register or memorialize the assignment of any rights to the Product Technology as provided under this Agreement, Perrigo hereby irrevocably designates and appoints Medicis and Medicis’ duly authorized officers and agents as Perrigo’s agents and attorneys-in-fact to act for and on Perrigo’s behalf and instead of Perrigo to take all lawfully permitted acts to further the filing, prosecution, registration, memorialization of assignment, issuance and enforcement of such rights, all with the same legal force and effect as if executed by Perrigo. The foregoing is deemed a power coupled with an interest and is irrevocable. Medicis shall have the world-wide right to control the drafting, filing, prosecution, maintenance and enforcement of patents covering the Product Technology and shall be fully responsible for related costs.
Product Technology. (a) Notwithstanding the terms of Sections 10.1, 10.2, and 10.3, any Joint Technology or VIT Technology directly related to the Compound or Product and arising directly from the Development of the Compound or Product under this Agreement that directly relates to (i) a pharmaceutical product with the same or similar chemical composition, formulation and mode of delivery of the Product, (ii) a pharmaceutical composition comprising the API of the Product, (iii) any amendment, change or improvement to the manufacturing process or specifications for the Product provided by ChemoCentryx to VIT, (iv) a new medical use of or method of using the Product (other than treatment algorithms or patient care programs), and (v) any combination of the API of the Product that includes at least one additional API other than the API of the Product (the “Product Technology”)), shall be the exclusive property of ChemoCentryx and the corresponding intellectual property rights shall be owned by ChemoCentryx.
Product Technology. Licensee shall be and remain the sole and exclusive owner of all rights, title and interest on a worldwide basis in and to the Product Technology (including the Product Patents), and, for that purpose, Licensor hereby assigns, and Licensor shall cause its Affiliates, employees, consultants, and agents to assign, its right, title, and interest in and to all Product Technology (including the Product Patents) to Licensee.
Product Technology. [***] shall solely own [***]. [***] hereby assigns to [***]. [***] shall perform, during and after the Term, [***] reasonably deems necessary or desirable to permit and assist [***], at [***] expense, in obtaining, perfecting and enforcing the full benefits, enjoyment, rights and title throughout the world in the [***]. [***] shall have the [***].
Product Technology. As between the Parties, HemoSense owns and shall continue to own all right, title and interest (including all patent and other intellectual-property rights) in and to (i) Coagulation Cocktail 2 and (ii) any inventions made by a Party or the Parties in connection with the performance of this Agreement or in connection with the development or manufacture of Coagulation Cocktail 2 prior to the date of this Agreement that primarily relate to Coagulation Cocktail 2 or constitute improvements to Coagulation Cocktail 2 (collectively, the “Product Technology”). Product Technology includes, but is not limited to, the compositions, formulations, recipes and specifications for Coagulation Cocktail 2.
Product Technology. Subject to the terms of this Agreement, Occam hereby grants to Tellabs a royalty-bearing (as set forth in Section 8), non-assignable (except as set forth in Section 16.3), non-transferable license under Occam’s intellectual property rights to:
Product Technology. Akili may disclose TALi Confidential Information comprising (whether in whole or in part) Product Technology only: